BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 11070012)

  • 21. [Studies on the molecular epidemiology of poliovirus type 1 in China].
    Liu HM; Guo CS; Wei WJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 1997 Aug; 18(4):208-10. PubMed ID: 9812519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Geographic distribution of wild poliovirus type 1 genotypes.
    Rico-Hesse R; Pallansch MA; Nottay BK; Kew OM
    Virology; 1987 Oct; 160(2):311-22. PubMed ID: 2821678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Complete Genome Characterization of Vaccine-derived Polioviruses Isolated in Yunnan,China].
    Tang J; Zhang J; Li K; Tian B; Zhao Z; Ding Z
    Bing Du Xue Bao; 2016 Jul; 32(4):459-64. PubMed ID: 29981280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rare natural type 3/type 2 intertypic capsid recombinant vaccine-related poliovirus isolated from a case of acute flaccid paralysis in Brazil, 2015.
    Cassemiro KMSM; Burlandy FM; da Silva EE
    J Gen Virol; 2016 Jul; 97(7):1545-1550. PubMed ID: 27082658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Genetic Characteristics of Type 2 Vaccine-derived Poliovirus in Shanxi Province (China) in 2014].
    Yan D; Li X; Zhang Y; Yang J; Zhu S; Wang D; Zhang C; Zhu H; Xu W
    Bing Du Xue Bao; 2015 Mar; 31(2):157-63. PubMed ID: 26164941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic recombination in wild-type poliovirus.
    Dahourou G; Guillot S; Le Gall O; Crainic R
    J Gen Virol; 2002 Dec; 83(Pt 12):3103-3110. PubMed ID: 12466487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genotype-specific in vitro amplification of sequences of the wild type 3 polioviruses from Mexico and Guatemala.
    Yang CF; De L; Yang SJ; Ruiz Gómez J; Cruz JR; Holloway BP; Pallansch MA; Kew OM
    Virus Res; 1992 Aug; 24(3):277-96. PubMed ID: 1329370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic divergence of poliovirus strains isolated in the Karachi region of Pakistan.
    Huovilainen A; Mulders MN; Agboatwalla M; Pöyry T; Stenvik M; Hovi T
    J Gen Virol; 1995 Dec; 76 ( Pt 12)():3079-88. PubMed ID: 8847513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolation of recombinant type 2 vaccine-derived poliovirus (VDPV) from a Nigerian child.
    Adu F; Iber J; Bukbuk D; Gumede N; Yang SJ; Jorba J; Campagnoli R; Sule WF; Yang CF; Burns C; Pallansch M; Harry T; Kew O
    Virus Res; 2007 Jul; 127(1):17-25. PubMed ID: 17449127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion.
    Martín J; Dunn G; Hull R; Patel V; Minor PD
    J Virol; 2000 Apr; 74(7):3001-10. PubMed ID: 10708414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mouse neurovirulence determinants of poliovirus type 1 strain LS-a map to the coding regions of capsid protein VP1 and proteinase 2Apro.
    Lu HH; Yang CF; Murdin AD; Klein MH; Harber JJ; Kew OM; Wimmer E
    J Virol; 1994 Nov; 68(11):7507-15. PubMed ID: 7933134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic analysis of wild-type poliovirus importation into The Netherlands (1979-1995).
    Mulders MN; Reimerink JH; Koopmans MP; van Loon AM; van der Avoort HG
    J Infect Dis; 1997 Sep; 176(3):617-24. PubMed ID: 9291306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phylogenetic analysis of wild-type 1 polioviruses isolated during the final period of transmission in Turkey.
    Özkaya E; Ishiko H; Miura R; Shimada Y; Alaeddinoglu I; Artuk C; Miyamura K; Yamazaki S
    J Gen Virol; 2004 Jun; 85(Pt 6):1591-1595. PubMed ID: 15166443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient.
    Kew OM; Sutter RW; Nottay BK; McDonough MJ; Prevots DR; Quick L; Pallansch MA
    J Clin Microbiol; 1998 Oct; 36(10):2893-9. PubMed ID: 9738040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nucleotide variation in Sabin type 3 poliovirus from an Albanian infant with agammaglobulinemia and vaccine associated poliomyelitis.
    Foiadelli T; Savasta S; Battistone A; Kota M; Passera C; Fiore S; Bino S; Amato C; Lozza A; Marseglia GL; Fiore L
    BMC Infect Dis; 2016 Jun; 16():277. PubMed ID: 27287521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genomic analysis of recombinant sabin clinical isolates.
    Paximadi E; Karakasiliotis I; Mamuris Z; Stathopoulos C; Krikelis V; Markoulatos P
    Virus Genes; 2006 Apr; 32(2):203-10. PubMed ID: 16604453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coinfection with recombinant vaccinia viruses expressing poliovirus P1 and P3 proteins results in polyprotein processing and formation of empty capsid structures.
    Ansardi DC; Porter DC; Morrow CD
    J Virol; 1991 Apr; 65(4):2088-92. PubMed ID: 1848318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term excretion of vaccine-derived poliovirus by a healthy child.
    Martín J; Odoom K; Tuite G; Dunn G; Hopewell N; Cooper G; Fitzharris C; Butler K; Hall WW; Minor PD
    J Virol; 2004 Dec; 78(24):13839-47. PubMed ID: 15564492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Limited expression of poliovirus by vaccinia virus recombinants due to inhibition of the vector by proteinase 2A.
    Jewell JE; Ball LA; Rueckert R
    J Virol; 1990 Mar; 64(3):1388-93. PubMed ID: 2154618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resolution of the pathways of poliovirus type 1 transmission during an outbreak.
    Shulman LM; Handsher R; Yang CF; Yang SJ; Manor J; Vonsover A; Grossman Z; Pallansch M; Mendelson E; Kew OM
    J Clin Microbiol; 2000 Mar; 38(3):945-52. PubMed ID: 10698978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.